| HR.1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | In Committee | 59 | Q3 2026 |
| S.832Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025 | In Committee | 41 | Q3 2026 |
| S.1040Drug Competition Enhancement Act | Introduced | 31 | Q3 2026 |
| S.1041Affordable Prescriptions for Patients Act | Introduced | 28 | Q3 2026 |
| HR.1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. | Signed | 24 | Q3 2026 |
| S.1097Interagency Patent Coordination and Improvement Act of 2025 | Introduced | 19 | Q3 2026 |
| S.1095Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the | Introduced | 18 | Q3 2026 |
| S.1096Preserve Access to Affordable Generics and Biosimilars Act | Introduced | 17 | Q3 2026 |
| HR.2214DRUG Act | In Committee | 14 | Q3 2026 |
| HR.5376Impacts and Outcomes for Health Career Training Act | In Committee | 13 | Q3 2026 |
| HR.3160Promoting and Respecting Economically Vital American Innovation Leadership Act or the PREVAIL Act | In Committee | 12 | Q3 2026 |
| S.1414Expedited Access to Biosimilars Act | Introduced | 12 | Q3 2026 |
| S.1553Promoting and Respecting Economically Vital American Innovation Leadership Act or the PREVAIL Act | In Committee | 12 | Q3 2026 |
| S.2658Medication Affordability and Patent Integrity Act | Introduced | 12 | Q3 2026 |
| S.43Skinny Labels, Big Savings Act | In Committee | 12 | Q3 2026 |
| S.891Bipartisan Health Care Act | In Committee | 12 | Q3 2026 |
| S.1954Biosimilar Red Tape Elimination Act | Introduced | 11 | Q3 2026 |
| S.864HELP Copays Act | In Committee | 11 | Q3 2026 |
| HCONRES.14Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. | Introduced | 10 | Q2 2026 |
| HR.3269ETHIC Act | In Committee | 10 | Q3 2026 |
| HR.4299Protecting Patient Access to Cancer and Complex Therapies Act | In Committee | 8 | Q3 2026 |
| HR.946Optimizing Research Progress Hope And New Cures Act or the ORPHAN Cures Act | Introduced | 8 | Q3 2026 |
| S.2296National Defense Authorization Act for Fiscal Year 2026 | Introduced | 8 | Q3 2026 |
| S.3345PBM Price Transparency and Accountability Act | In Committee | 8 | Q3 2026 |
| S.355FDA Modernization Act 3.0 | Introduced | 8 | Q3 2026 |
| HR.1262Give Kids a Chance Act of 2025 | Introduced | 7 | Q2 2026 |
| HR.4317PBM Reform Act of 2025 | In Committee | 7 | Q3 2026 |
| HR.5378Tribal Healthcare Careers Act | In Committee | 7 | Q3 2026 |
| HR.6283FOSTER Act | In Committee | 7 | Q3 2026 |
| HR.6485Skinny Labels, Big Savings Act | In Committee | 7 | Q3 2026 |
| HR.830Save Americans from the Fentanyl Emergency Act or the SAFE Act | In Committee | 7 | Q3 2026 |
| HR.890Stopping Pharma’s Ripoffs and Drug Savings For All Act | In Committee | 7 | Q3 2026 |
| S.1542Uyghur Policy Act of 2026 | Introduced | 7 | Q3 2026 |
| S.2256Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 | Introduced | 7 | Q3 2026 |
| S.527Prescription Pricing for the People Act of 20 | Introduced | 7 | Q3 2026 |
| S.652Protecting Patients from Deceptive Drug Ads Act | In Committee | 7 | Q3 2026 |
| HR.2213Medical Supply Chain Resiliency Act | In Committee | 6 | Q3 2026 |
| HR.3152Patent Eligibility Restoration Act of 2025 | In Committee | 6 | Q3 2026 |
| HR.4121Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 | Introduced | 6 | Q3 2026 |
| S.1546Patent Eligibility Restoration Act of 2025 | In Committee | 6 | Q3 2026 |
| S.2276ETHIC Act | In Committee | 6 | Q3 2026 |
| S.2620Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act | In Committee | 6 | Q3 2026 |
| S.932Give Kids a Chance Act of 2025 | In Committee | 6 | Q1 2026 |
| HR.1574Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 or the RESTORE Patent Rights Act of 2025 | In Committee | 5 | Q1 2026 |
| HR.4570Interagency Patent Coordination and Improvement Act of 2025 | In Committee | 5 | Q3 2026 |
| HR.5256340B ACCESS Act | In Committee | 5 | Q3 2026 |
| HR.5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 | Introduced | 5 | Q3 2026 |
| HR.5342Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 | Introduced | 5 | Q3 2026 |
| HR.7148Consolidated Appropriations Act, 2026 | Signed | 5 | Q3 2026 |
| HR.8646Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 | Introduced | 5 | Q3 2026 |
| HRES.566Providing for consideration of the Senate amendment to the bill (H.R. 1) to provide for reconciliation pursuant to title II of H. Con. Res. 14. | Introduced | 5 | Q2 2026 |
| S.1071National Defense Authorization Act for Fiscal Year 2026 | Signed | 5 | Q3 2026 |
| S.2354Commerce, Justice, Science, and Related Agencies Appropriations Act, 2026 | Introduced | 5 | Q3 2026 |
| S.2587Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 | Introduced | 5 | Q3 2026 |
| S.3014Ensuring Timely Access to Generics Act of 2025 | In Committee | 5 | Q3 2026 |
| S.3788Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act or the CLEAR LABELS Act | Introduced | 5 | Q3 2026 |
| S.4784National Defense Authorization Act for Fiscal Year 2027 | Introduced | 5 | Q3 2026 |
| S.708Realizing Engineering, Science, and Technology Opportunities by Restoring Exclusive Patent Rights Act of 2025 or the RESTORE Patent Rights Act of 2025 | In Committee | 5 | Q1 2026 |
| HR.3838Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 | Introduced | 4 | Q4 2025 |
| HR.3944Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2026 | Introduced | 4 | Q1 2026 |
| HR.4213Department of Homeland Security Appropriations Act, 2026 | Introduced | 4 | Q1 2026 |
| HR.4780Use Sovereignty To reduce Rx Act or the USTRx Act | In Committee | 4 | Q3 2026 |
| HR.5526Biosimilar Red Tape Elimination Act | In Committee | 4 | Q3 2026 |
| HR.6423HELP Copays Act | In Committee | 4 | Q3 2026 |
| HR.7953FAIR ACT | In Committee | 4 | Q3 2026 |
| HR.8800National Defense Authorization Act for Fiscal Year 2027 | Introduced | 4 | Q3 2026 |
| HR.9260Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 | Introduced | 4 | Q3 2026 |
| HR.2821FDA Modernization Act 3.0 | Introduced | 3 | Q4 2025 |
| HR.5371Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 | Signed | 3 | Q2 2026 |
| HR.6938Commerce, Justice, Science; Energy and Water Development; and Interior and Environment Appropriations Act, 2026 | Signed | 3 | Q3 2026 |
| HR.7837Most Favored Patient Act of 2026 | In Committee | 3 | Q3 2026 |
| HR.8269CLEAR LABELS Act | In Committee | 3 | Q3 2026 |
| HR.9661Expedited Access to Biosimilars Act | In Committee | 3 | Q3 2026 |
| S.1302Increasing Transparency in Generic Drug Applications Act | In Committee | 3 | Q4 2025 |
| S.1637Medicaid VBPs for Patients Act or the MVP Act | In Committee | 3 | Q1 2026 |
| SCONRES.7An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034. | Introduced | 3 | Q1 2025 |
| HR.1968Full-Year Continuing Appropriations and Extensions Act, 2025 | Signed | 2 | Q1 2025 |
| HR.3521Clinical Trial Modernization Act | In Committee | 2 | Q3 2026 |
| HR.4Rescissions Act of 2025 | Signed | 2 | Q2 2026 |
| HR.6610Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] | Introduced | 2 | Q3 2026 |
| HR.6624Biological Intellectual Property Protection Act of 2025 | Introduced | 2 | Q3 2026 |
| HR.7391Community Health Center Drug Pricing Protection Act | In Committee | 2 | Q3 2026 |
| HR.9102BINSA Act | In Committee | 2 | Q3 2026 |
| HR.9142Prohibiting Adversarial Patents Act of 2026 | In Committee | 2 | Q3 2026 |
| HR.9504Tax Exempt Hospital Transparency Act | Introduced | 2 | Q3 2026 |
| S.1387National Biotechnology Initiative Act of 2025 | In Committee | 2 | Q3 2026 |
| S.3452Biological Intellectual Property Protection Act of 2025 | In Committee | 2 | Q3 2026 |
| S.705Innovation in Pediatric Drugs Act of 2025 | In Committee | 2 | Q1 2025 |
| S.839Safeguarding Honest Speech Act | In Committee | 2 | Q3 2025 |
| HR.10628Biosimilars Access and Affordability Act | In Committee | 1 | Q3 2026 |
| HR.1843To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. | In Committee | 1 | Q4 2025 |
| HR.2715Destruction of Hazardous Imports Act | In Committee | 1 | Q2 2026 |
| HR.2882Central Coast of California Conservation Act of 2025 | In Committee | 1 | Q1 2025 |
| HR.3701Family Vaccine Protection Act | In Committee | 1 | Q2 2025 |
| HR.4132Prescription Information Modernization Act of 2025 | In Committee | 1 | Q2 2025 |
| HR.4370SAMS Act of 2025 | In Committee | 1 | Q1 2025 |
| HR.6089Biomanufacturing Excellence Act of 2025 | In Committee | 1 | Q2 2026 |
| HR.6500Continuing Appropriations and Extensions Act, 2027 | Signed | 1 | Q3 2026 |
| HR.6509Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2025 or the SAFE Drugs Act of 2025 | In Committee | 1 | Q3 2026 |
| HR.7140CLEAR Act | In Committee | 1 | Q1 2026 |
| HR.8574U.S. in Expos Act | In Committee | 1 | Q2 2025 |
| HR.8845Commerce, Justice, Science, and Related Agencies Appropriations Act, 2027 | Introduced | 1 | Q2 2026 |
| HR.9026To designate the facility of the United States Postal Service located at 80 Atlantic Avenue in Oceanside, New York, as the "Detective Luis G. Alvarez Post Office". | Introduced | 1 | Q1 2025 |
| HR.9027Military and Veterans Fuel Discount Act of 2026 | In Committee | 1 | Q1 2025 |
| HR.9029Coal Cleanup Taxpayer Protection Act of 2026 | In Committee | 1 | Q1 2025 |
| HR.9310Department of Homeland Security Appropriations Act, 2027 | Introduced | 1 | Q2 2026 |
| HR.950Saving Seniors Money on Prescriptions Act | In Committee | 1 | Q1 2025 |
| HR.9599SECURE 340B Act | In Committee | 1 | Q3 2026 |
| S.1784Mapping America’s Pharmaceutical Supply Act or the MAPS Act | In Committee | 1 | Q2 2025 |
| S.2Secure America Act | Signed | 1 | Q2 2026 |
| S.2220Fighting for the Overlooked Recognition of Groups Operating in Toxic Test Environments in Nevada (FORGOTTEN) Veterans Act of 2025 | In Committee | 1 | Q1 2025 |
| S.2710Open Payments Expansion Act | In Committee | 1 | Q4 2025 |
| S.2780No Tax on Large Party Tips Act | In Committee | 1 | Q2 2025 |
| S.3794Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2026 or the SAFE Drugs Act of 2026 | Introduced | 1 | Q3 2026 |
| S.4023America’s Living Library Act | In Committee | 1 | Q1 2026 |
| S.4098Artificial Intelligence-Ready Data Act | In Committee | 1 | Q1 2026 |
| S.4189INSULIN Act of 2026 | Introduced | 1 | Q3 2026 |
| S.4690Encouraging Public Offerings Act of 2026 | In Committee | 1 | Q1 2025 |
| S.4795FREEDOM Act | In Committee | 1 | Q1 2025 |
| S.4942SAFE Banking Act of 2026 | In Committee | 1 | Q1 2025 |
| S.5043Secure Drug Supply Chain Act of 2026 | In Committee | 1 | Q3 2026 |
| S.5244SUSTAIN 340B Act | In Committee | 1 | Q3 2026 |
| S.5265USTRx Act | In Committee | 1 | Q3 2026 |
| S.5316BINSA Act | In Committee | 1 | Q3 2026 |
| S.5571A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program. | In Committee | 1 | Q3 2026 |
| S.863Genomic Data Protection Act | In Committee | 1 | Q3 2025 |